Nanotechnology-based test can quickly diagnose Zika virus

Image
IANS New York
Last Updated : Aug 12 2017 | 4:22 PM IST

Scientists, including one of Indian-origin, have developed a nanotechnology-based test that can quickly detect the presence of the Zika virus in the blood, an advance that may also be applicable to other emerging infectious diseases.

Currently, testing for Zika requires that a blood sample be refrigerated and shipped to a medical centre or laboratory, delaying diagnosis and possible treatment.

The new test, however, relies on a protein made by the Zika virus that causes an immune response in infected individuals, which is then attached to tiny gold nanorods mounted on a piece of paper.

The paper then is completely covered with tiny, protective nanocrystals. The nanocrystals allow the diagnostic nanorods to be shipped and stored without refrigeration prior to use, the researchers said.

"If an assay requires electricity and refrigeration, it defeats the purpose of developing something to use in a resource-limited setting, especially in tropical areas of the world," said Srikanth Singamaneni, Associate Professor at the Washington University in St. Louis.

"We wanted to make the test immune from variations in temperature and humidity," Singamaneni added.

When a drop of the patient's blood is applied on the paper mounted on the nanorods, the immunoglobulins in the blood will react with the protein if the patient has come into contact with the virus and demonstrate a colour change.

"The immunoglobulins persist in the blood for a few months, and when they come into contact with the gold nanorods, the nanorods undergo a slight colour change that can be detected with a hand-held spectrophotometer," explained Jeremiah J. Morrissey, Professor at the varsity.

"With this test, results will be clear before the patient leaves the clinic, allowing immediate counselling and access to treatment," he added in the paper detailed in the journal Advanced Biosystems.

As other infectious diseases emerge around the world, similar strategies potentially could be used to develop tests to detect the presence of viruses that may become problematic, the researchers said.

--IANS

rt/amit/bg

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Aug 12 2017 | 4:08 PM IST

Next Story